Back
Archer-Daniels Midland Vs. Crinetics Pharmaceuticals Industry Stock Comparison
Sell
33
ADM
Archer-Daniels Midland
Last Price:
$50.90
Seasonality Move:
-0.11%
Sell
2
CRNX
Crinetics Pharmaceuticals
Last Price:
$38.22
Seasonality Move:
-6.74%
Sell
33
Archer-Daniels Midland (ADM)
is a Sell
Is Archer-Daniels Midland a Buy, Sell or Hold?
-
The current Archer-Daniels Midland [ADM] share price is $52.12. The Score for ADM is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ADM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
2
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals [CRNX] share price is $38.98. The Score for CRNX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
ADM Stock Price Chart
What is Archer-Daniels Midland's stock price today?
-
The Archer-Daniels Midland share price today is $52.12The current trend is relatively stagnant and ADM is experiencing slight buying pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $38.98Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.
ADM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 56.43 | Buy |
Chaikin Money Flow: | 1675414 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.89 - 52.05) | Buy |
Bollinger Bands (100): | (51.77 - 59.45) | Sell |
CRNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.13 | Sell |
Relative Strength Index (14 RSI): | 21.13 | Sell |
Chaikin Money Flow: | -690740 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.93 - 57.37) | Sell |
Bollinger Bands (100): | (50.63 - 57.85) | Sell |
ADM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.36 | Buy |
20-day SMA: | 50.68 | Buy |
50-day SMA: | 52.14 | Sell |
200-day SMA: | 58.53 | Sell |
8-day EMA: | 50.66 | Buy |
20-day EMA: | 50.88 | Buy |
50-day EMA: | 52.44 | Sell |
200-day EMA: | 58.06 | Sell |
CRNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.98 | Sell |
20-day SMA: | 51.29 | Sell |
50-day SMA: | 54.96 | Sell |
200-day SMA: | 50.99 | Sell |
8-day EMA: | 46.42 | Sell |
20-day EMA: | 50.33 | Sell |
50-day EMA: | 53.11 | Sell |
200-day EMA: | 49.76 | Sell |
Archer-Daniels Midland Earnings Growth & ADM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.09 per share.
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.
Archer-Daniels Midland Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Crinetics Pharmaceuticals Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |